Six Vidipha executives seek to resign after nearly 34% of shares change hands
Vietnamese pharmaceutical company Vidipha disclosed on November 13, 2026, that its chairman and five other directors and supervisors had submitted resignations, subject to shareholder approval. The executives and their relatives had previously sold nearly 7.5 million shares, representing about 34% of the company’s share capital. Revenue and pre-tax profit rose year on year in the first nine months.
